ESOPHAGEAL SQUAMOUS CELL CANCER
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CANCER trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control Recruiting nowThis is the first study in people to test a new cancer drug called KIVU-107. The main goal is to find a safe dose and see how well the body handles it. It is for adults with advanced solid tumors that have spread or cannot be removed by surgery and have stopped responding to avai…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CANCER
Phase: PHASE1 • Sponsor: Kivu Bioscience Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
New hope for advanced cancer patients as experimental drug trial begins
Disease control Recruiting nowThis is the first study in people to test a new drug called XB010 for advanced solid tumors. The main goals are to find a safe dose and see how the body handles the drug, both by itself and when combined with another cancer therapy. It is for adults with certain advanced cancers …
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CANCER
Phase: PHASE1 • Sponsor: Exelixis • Aim: Disease control
Last updated Feb 23, 2026 14:51 UTC